James E. Besser - 02 Oct 2023 Form 4 Insider Report for Modular Medical, Inc. (MODD)

Reporting relationship: Chief Executive Officer, 10%+ Owner
Issuer ticker: MODD
Reported as of: 02 Oct 2023
Net transaction value: +$150,001
SEC form: 4
Accepted by SEC: 04 Oct 2023, 18:00:43 UTC
Source filing: View source filing
Reporting owner signature: James E. Besser By: /s/ James E. Besser

Key filing fact

James E. Besser filed Form 4 for Modular Medical, Inc. (MODD) on 04 Oct 2023.

Key facts

This page summarizes James E. Besser's Form 4 filing for Modular Medical, Inc. (MODD).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 04 Oct 2023, 18:00.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: +$150,001.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MODD transaction Derivative

Option to purchase common stock

Award

Transaction value: $150,001
Shares: +135,136
Change %
Price: $1.11
Shares after: 135,136
Date: 02 Oct 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 135,136
Exercise price: $1.11
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

This option shall vest as to all of the shares subject to the option if (i) all verification and validation testing for the Registrant's initial pump product is completed by December 31, 2023 and (ii) the 510(K) premarket submission to the U.S. Food and Drug Administration ("FDA") for the Registrant's initial pump product must be completed by January 31, 2024. If criteria (i) and (ii) are not both achieved, the option will not vest as to any of the shares and will terminate on February 1, 2024.

Footnote F2

In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in Column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."